Notes for: Central nervous systemLast edited [10/12/2021 11:31:41]
‘Safety First: Five-Year Report of the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness’ recommends that patients at risk of suicide, including all patients with a recent history of self-harm, who are treated with psychotropic drugs should receive modern, less toxic drugs and/or supplies lasting no more than 2 weeks.
Notes for: Essentialtremor,Chorea,Tics&ReldisordersLast edited [15/08/2011 13:13:43]
Guidance on the use of riluzole for the treatment of motor neurone disease was issued by NICE in January 2001. Riluzole is recommended for the treatment of individuals with the amyotrophic lateral sclerosis (ALS) form of Motor Neurone Disease (MND). A neurological specialist should initiate therapy with expertise in the management of MND. Routine supervision of therapy should be managed by locally agreed shared care protocols undertaken by general practitioners.